1. MiR-1224 Acts as a Prognostic Biomarker and Inhibits the Progression of Gastric Cancer by Targeting SATB1
   Guo-Dong Han et al, 2021, Frontiers in Oncology CrossRef
2. A Potential Target for Clinical Atherosclerosis: A Novel Insight Derived from TPM2
   Ling-bing Meng et al, 2022, Aging and disease CrossRef
3. Aberrant DNA Methylation-Mediated FOXF2 Dysregulation Is a Prognostic Risk Factor for Gastric Cancer
   Cheng Zhang et al, 2021, Frontiers in Molecular Biosciences CrossRef
4. Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
   Qingfan Yang et al, 2022, Frontiers in Oncology CrossRef
5. Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer
   Xingchen Zhou et al, 2024, International Journal of General Medicine CrossRef
6. Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
   Miao Su et al, 2021, Frontiers in Genetics CrossRef
7. Carnosol attenuated atrophy of C2C12 myotubes induced by tumour‐derived exosomal miR‐183‐5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration
   Ji‐Xia Kuang et al, 2022, Basic & Clinical Pharmacology & Toxicology CrossRef
8. Bioinformatics and pathway enrichment analysis identified hub genes and potential biomarker for gastric cancer prognosis
   Elham Darang et al, 2023, Frontiers in Oncology CrossRef
9. Deciphering the significance of anoikis in bladder cancer and systematic analysis of S100A7 as a potential therapeutic target
   Haoran Wang et al, 2024, European Journal of Medical Research CrossRef